Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in CLBP therapeutics.

There will be more than 344 million prevalent cases of CLBP in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast.

Chronic pain continues to be a significant global burden despite the availability of a variety of nonpharmacologic and pharmacologic treatment options.

R&D activity in CLBP is robust globally, with nine molecules in Phase III development.

Commercial sponsors dominate clinical trial development in CLBP, with Iran, the US, and Russia emerging as the key countries for conducting Phase III trials in CLBP.

Deals involving acquisitions and partnerships were the most common types of deals globally involving companies developing CLBP assets.

Scope

GlobalData’s CLBP: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include -

Disease Landscape

Disease Overview

Epidemiology Overview

Treatment Overview

Marketed Products Assessment

Breakdown by Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Pricing and Reimbursement Assessment

Annual Therapy Cost

Time to Pricing and Time to Reimbursement

Pipeline Assessment

Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Late-to-mid-stage Pipeline Drugs

Phase Transition Success Rate and Likelihood of Approval

Clinical Trials Assessment

Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status

Enrolment Analytics, Site Analytics, Feasibility Analysis

Deals Landscape

Mergers, Acquisitions, and Strategic Alliances by Region

Overview of Recent Deals

Commercial Assessment

Key Market Players

Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the CLBP market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CLBP market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.